Clinical Trials on 颈椎间盘疾病 in China
总计31877个结果
-
Tongji HospitalZhejiang Cancer Hospital; Xiangya Hospital of Central South University; Beijing Friendship Hospital 和其他合作者尚未招聘
-
GlaxoSmithKline完全的
-
Tongji HospitalZhejiang Cancer Hospital; Xiangya Hospital of Central South University; Beijing Friendship Hospital 和其他合作者尚未招聘
-
Xi'an International Medical Center HospitalSecond Affiliated Hospital of Xi'an Jiaotong University尚未招聘
-
Sichuan Cancer Hospital and Research Institute尚未招聘
-
Xiamen UniversityXiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.尚未招聘
-
Xiamen Ophthalmology Center Affiliated to Xiamen...Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.主动,不招人
-
Qi Zhou尚未招聘1. 复发性卵巢癌 2. 转移性卵巢癌 3. 子宫内膜癌 4. 宫颈癌中国
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫疗法 | 生存结果 | 免疫检查点抑制剂 | 客观反应率 | 转移性宫颈癌 | 替雷利珠单抗 | 持续性宫颈癌 | 抗程序性细胞死亡受体 1中国
-
Fourth Affiliated Hospital of Guangxi Medical University招聘中
-
Xinqiao Hospital of ChongqingTCRCure Biopharma Ltd.未知
-
Peking Union Medical College HospitalPeking University First Hospital; Zhejiang Cancer Hospital; Xiangya Hospital of Central South... 和其他合作者招聘中
-
Xiamen UniversityXiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.完全的
-
Peking University People's HospitalHangzhou Newhorizon Health Technology Co., Ltd.; Hangzhou Mingze Medical Research Co., Ltd.; Beijing...招聘中宫颈癌 | 宫颈腺癌 | 宫颈鳞状细胞癌 | 人乳头瘤病毒感染 | 人乳头瘤病毒 | 原位腺癌 | 高级别鳞状上皮内病变 | 宫颈上皮内瘤变 II 级 | 宫颈上皮内瘤变,III 级 | 意义未明的非典型鳞状细胞 | 非典型鳞状细胞,不能排除高度鳞状上皮内病变 | 宫颈鳞状上皮内病变 | 宫颈上皮内瘤变Ⅰ级 | 非典型腺细胞 | 未特指的非典型腺细胞 | 非典型腺细胞,有利于肿瘤 | 上皮内病变或恶性肿瘤阴性 | 低度鳞状上皮内病变中国
-
First Affiliated Hospital of Chongqing Medical...未知
-
Shanghai University of Traditional Chinese MedicineTianjin University of Traditional Chinese Medicine未知
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.撤销
-
Wangjing Hospital, China Academy of Chinese Medical...First Teaching Hospital of Tianjin University of Traditional Chinese Medicine; Affiliated Hospital... 和其他合作者尚未招聘
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫检查点抑制剂 | 总生存期 | 抗程序性死亡-1 抗体 | 转移性宫颈癌 | 持续性晚期宫颈癌 | 客观缓解率 | 无进展生存期 | 严重不良事件中国
-
Mundipharma (China) Pharmaceutical Co. Ltd完全的
-
Peking Union Medical College HospitalPeking University Cancer Hospital & Institute; Beijing Obstetrics and Gynecology Hospital; Precision...招聘中
-
Korea Cancer Center HospitalAsan Medical Center; Seoul National University Hospital; Gangnam Severance Hospital招聘中
-
Chang Gung Memorial HospitalSinphar Pharmaceutical Co., Ltd未知
-
Zhongnan HospitalBinhui Biopharmaceutical Co., Ltd.招聘中
-
Obstetrics & Gynecology Hospital of Fudan UniversityPeking Union Medical College Hospital; First Affiliated Hospital of Xinjiang Medical University 和其他合作者尚未招聘
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
Peking University People's HospitalBeijingNewBiorayTechnologyCo.,Ltd.; Hangzhou Newhorizon Health Technology Co., Ltd.主动,不招人宫颈癌 | 宫颈腺癌 | 宫颈鳞状细胞癌 | 人乳头瘤病毒感染 | 原位腺癌 | 低度鳞状上皮内病变 | 高级别鳞状上皮内病变 | 宫颈上皮内瘤变 II 级 | 宫颈上皮内瘤变,III 级 | 上皮内病变或恶性肿瘤阴性 | 意义未明的非典型鳞状细胞 | 非典型鳞状细胞,不能排除高度鳞状上皮内病变 | 宫颈鳞状上皮内病变 | 宫颈上皮内瘤变Ⅰ级 | 非典型腺细胞 | 未特指的非典型腺细胞 | 非典型腺细胞,有利于肿瘤中国
-
Peking Union Medical College HospitalShanghai Reunion Biotech Co.,Ltd.招聘中
-
Tongji HospitalNational Natural Science Foundation of China尚未招聘
-
The Cleveland ClinicNational Cancer Institute (NCI); University of Southern California; Medical College of Wisconsin; Peking University Shenzhen Hospital 和其他合作者主动,不招人